Francesco Zonta

ANUBI optimizes protein and peptide drug candidates by simulating sequence space and binding affinity calculations, improving target binding efficiency and reducing costs.

This study demonstrates that gH625-modified chromatin enhances transdermal delivery of EGF, showing comparable biological activity to free EGF in cells.

This study compares computational methods for calculating antibody binding affinities and finds equilibrium MMPBSA outperforms other methods for a specific antibody-peptide system.